Publicacións nas que colabora con Alfonso Leal Cerro (24)

2011

  1. Expression of functional KISS1 and KISS1R system is altered in human pituitary adenomas: Evidence for apoptotic action of kisspeptin-10

    European Journal of Endocrinology, Vol. 164, Núm. 3, pp. 355-362

2006

  1. Ghrelin is produced by and directly activates corticotrope cells from adrenocorticotropin-secreting adenomas

    Journal of Clinical Endocrinology and Metabolism, Vol. 91, Núm. 6, pp. 2225-2231

2005

  1. Prevalence of hypopituitarism and growth hormone deficiency in adults long-term after severe traumatic brain injury

    Clinical Endocrinology, Vol. 62, Núm. 5, pp. 525-532

2003

  1. Effect of acute reduction of free fatty acids by acipimox on growth hormone-releasing hormone-induced GH secretion in type 1 diabetic patients

    Clinical Endocrinology, Vol. 59, Núm. 4, pp. 431-436

  2. Mechanisms underlying the neuroendocrine response to physical exercise

    Journal of Endocrinological Investigation, Vol. 26, Núm. 9, pp. 879-885

2002

  1. Effect of withdrawal of somatostatin plus GH-releasing hormone as a stimulus of GH secretion in obesity

    Clinical Endocrinology, Vol. 56, Núm. 4, pp. 487-492

  2. Effect of withdrawal of somatostatin plus growth hormone (GH)-releasing hormone as a stimulus of GH secretion in Cushing's syndrome

    Clinical Endocrinology, Vol. 57, Núm. 6, pp. 745-749

  3. Ghrelin is no longer able to stimulate growth hormone secretion in patients with Cushing's syndrome but instead induces exaggerated corticotropin and cortisol responses

    Neuroendocrinology, Vol. 76, Núm. 6, pp. 390-396

2001

  1. Influence of cortisol status on leptin secretion

    Pituitary, Vol. 4, Núm. 1-2, pp. 111-116

  2. Physiology and possible pathology of growth hormone secretagogues

    Journal of Pediatric Endocrinology and Metabolism, Vol. 14, Núm. SUPPL. 5, pp. 1207-1212

1999

  1. The growth hormone (GH)-releasing hormone - GH - insulin-like growth factor-1 axis in patients with fibromyalgia syndrome

    Journal of Clinical Endocrinology and Metabolism, Vol. 84, Núm. 9, pp. 3378-3381

1998

  1. Enhanced growth hormone (GH) responsiveness to GH-releasing hormone after dietary restriction in patients with Cushing's syndrome

    Clinical Endocrinology, Vol. 48, Núm. 1, pp. 117-121

  2. Serum leptin levels in male marathon athletes before and after the marathon run

    Journal of Clinical Endocrinology and Metabolism, Vol. 83, Núm. 7, pp. 2376-2379

  3. Theoretical considerations in estimating the growth hormone axis in adults

    Growth Hormone and IGF Research, Vol. 8, Núm. SUPPL. 2, pp. 93-96

1997

  1. Acute pharmacological reduction of plasma free fatty acids enhances the growth hormone (GH)-releasing hormone-mediated GH secretion in patients with Cushing's syndrome

    Journal of Clinical Endocrinology and Metabolism, Vol. 82, Núm. 9, pp. 3165-3168

  2. Neuropharmacological assessment of growth hormone secretion

    Acta Paediatrica, International Journal of Paediatrics, Supplement

1996

  1. Growth hormone releasing hexapeptide-6 (GHRP-6) in test in the diagnosis of GH-deficiency

    Journal of Pediatric Endocrinology and Metabolism

  2. Role of glucocorticoids in the neuroregulation of growth hormone secretion

    Journal of Pediatric Endocrinology and Metabolism

  3. Serum immunoreactive-leptin levels are increased in patients with Cushing's syndrome

    Hormone and Metabolic Research, Vol. 28, Núm. 12, pp. 711-713

1995

  1. Growth hormone (GH) responses to the combined administration of GH-releasing hormone plus GH-releasing peptide 6 in adults with GH deficiency

    European Journal of Endocrinology, Vol. 132, Núm. 6, pp. 712-715